U.K. May Turn To “Value-Based” Drug Pricing In Place Of Price Limits

The British Department of Health has notified drug companies that it is ending the current Pharmaceutical Pricing Regulation Scheme as of Aug. 31 and will examine other approaches, such as "value-based" drug pricing